I. Lautenschlager et al., EFFECT OF CYTOMEGALOVIRUS ON AN EXPERIMENTAL-MODEL OF CHRONIC RENAL-ALLOGRAFT REJECTION UNDER TRIPLE-DRUG TREATMENT IN THE RAT, Transplantation, 64(3), 1997, pp. 391-398
Background. Cytomegalovirus (CMV) infection is thought to be a risk fa
ctor of chronic rejection. In clinical studies and animal models, main
ly concerning graft vasculopathy, CMV has been demonstrated to enhance
allograft arteriosclerosis, In this study we have investigated the ef
fect of CMV on the early inflammatory response and graft histology in
an experimental model of renal transplantation in a rat strain combina
tion that develops chronic rejection under triple-drug immunosuppressi
on. Methods. Renal transplantations were performed in a rat strain com
bination of DA-->BN receiving triple-drug treatment (2 mg/kg methylpre
dnisolone, 2 mg/kg azathioprine, 5 mg/kg cyclosporine daily subcutaneo
usly). One group of immunosuppressed animals was infected with rat CMV
, the Maastricht strain (10(5) plaque-forming units intraperitoneally)
, and the other group was left uninfected, As a positive control for a
lloresponse, one group of recipients received neither immunosuppressio
n nor virus. Syngenic transplantations with triple-drug treatment and
CMV were used as negative controls. The grafts were monitored by frequ
ent ultrasound-guided fine-needle aspiration biopsies, and the intragr
aft inflammation was quantified in detail by the increment method and
expressed in corrected increment units (CIU). Graft histology was perf
ormed in parallel. Results. Nonimmunosuppressed animals developed acut
e rejection with a high peak of inflammation (7.9+/-3.2 CIU), a typica
l blast response, and lymphocytosis followed by infiltration of macrop
hages and necrosis within 7 days. Triple drug-treated animals had a sh
ort, mild inflammatory response (3.3+/-1.4 CIU at the peak) in the gra
ft 3-5 days after transplantation but ended up with histological chang
es characteristic of chronic rejection with vasculopathy and fibrosis
40-60 days later. Triple drug-treated animals with CMV demonstrated a
significantly stronger inflammation (4.5+/-1.8 CIU, P<0.01) than those
without, and lymphoid activation continued longer and was followed by
infiltration of macrophages in the graft. CMV infection of the graft
was demonstrated by viral culture and antigen detection. In histology,
chronic rejection with intimal thickening of arteries and arterioles
and medial necrosis of large arteries was seen at 14 days, ending up w
ith remarkable graft fibrosis within 20 days after transplantation. Co
nclusion. CMV prolonged and increased graft inflammation and accelerat
ed chronic rejection of renal allografts under triple-drug treatment.